PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAspartame
Aspartame
Aspartame is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
discount drug mart eye drops advanced reliefOTC monograph final2023-03-20
equalactin laxativeC2002632024-12-18
equalineOTC monograph not final2019-02-15
equaline 12 hour decongestantANDA2023-08-03
equaline acetaminophenC2002632024-11-13
equaline adult tussinC2002632024-11-10
equaline advanced relief eye dropsC2002632023-12-20
equaline all day allergyANDA2023-08-02
equaline allergyC2002632024-09-29
equaline allergy reliefANDA2024-12-10
Show 80 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
90 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AnemiaD000740EFO_0004272D64.9112
Multiple sclerosisD009103EFO_0003885G3522
SclerosisD01259822
Human influenzaD007251EFO_0007328J11.111
NeoplasmsD009369C8011
Rheumatoid arthritisD001172EFO_0000685M06.911
ArthritisD001168EFO_0005856M05-M1411
Chronic progressive multiple sclerosisD020528EFO_000384011
LymphomaD008223C85.911
Large b-cell lymphoma diffuseD016403C83.311
Show 5 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD00228911
Lung neoplasmsD008175C34.9011
Pancreatic neoplasmsD010190EFO_0003860C2511
Neoplasm metastasisD009362EFO_000970811
Lupus nephritisD008181EFO_000576111
NephritisD009393N0511
Breast neoplasmsD001943EFO_0003869C5011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD01517911
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAspartame
INNaspartame
Description
Aspartame is a dipeptide obtained by formal condensation of the alpha-carboxy group of L-aspartic acid with the amino group of methyl L-phenylalaninate. Commonly used as an artificial sweetener. It has a role as a sweetening agent, a nutraceutical, a micronutrient, a xenobiotic, an environmental contaminant, an apoptosis inhibitor and an EC 3.1.3.1 (alkaline phosphatase) inhibitor. It is a dipeptide, a carboxylic acid and a methyl ester. It is functionally related to a L-aspartic acid and a methyl L-phenylalaninate. It is a tautomer of an aspartame zwitterion.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O
Identifiers
PDB
CAS-ID22839-47-0
RxCUI
ChEMBL IDCHEMBL171679
ChEBI ID2877
PubChem CID134601
DrugBankDB00168
UNII IDZ0H242BBR1 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 2,229,006 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,562 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use